i) While a write-down to NRV is treated as an expense in SOPL, would a reversal of the write-down be treated as income?
ii) In consolidation questions, what portion of the revaluation surplus would the NCI take on the SOFP? Only the subsidiary’s or both the parent+subsidiary? Also, do we only take the NCI% of the year-end balance or the just the post-acquisition movement?
iii) And finally, are we permitted to use abbreviations such as SOPL, SOFP, OCI & NCI in the exams?
i) We wouldn’t reverse the write-down. We may subsequently sell it for more, but that is then accounted for as revenue.
ii) We take the NCI% of the post acquisition movement of the revaluation surplus/other components of equity.
iii) There are no presentation marks in the exam so you couldn’t be penalised.
Thanks and glad you like the website.
Author
Posts
Viewing 2 posts - 1 through 2 (of 2 total)
You must be logged in to reply to this topic.
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy